OTC · Medical - Instruments & Supplies

Biotage AB (publ) (BITGF) Stock

$15.01 +0.00% OTC: BITGF Healthcare

Biotage AB (publ) specializes in advanced separation science solutions for organic and analytical chemistry, biomolecular research, and industrial-scale applications. The company's comprehensive offerings include products for organic and peptide synthesis, flash chromatography, evaporation, and sample work-up, alongside a variety of flash systems, accessories, and chromatographic cartridges (normal, reversed, and specialized phases).

Valuation

MetricValue
Price$15.01
Market Cap$1.20B
P/E Ratio40.34
P/B Ratio2.79
P/S Ratio5.58
EPS (TTM)$0.37
52-Week High$18.52
52-Week Low$11.50
Dividend Yield1.13%

Financials & Margins

MetricValue
ROE7.31%
ROA5.56%
ROCE8.47%
Gross Margin62.69%
Operating Margin18.63%
Net Margin13.81%
Debt/Equity0.06
Current Ratio2.33

Annual Financials (USD)

Metric20202021202220232024
Revenue$1.1B$1.2B$1.6B$1.9B$2.1B
Operating Profit$206.0M$271.0M$327.0M$314.0M$383.0M
Net Profit$175.0M$205.0M$268.0M$246.0M$284.0M
EPS$2.68$3.13$4.04$3.33$3.55
Op Margin18.9%22.0%20.9%16.9%18.6%

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$1.4B$2.0B$2.3B$4.9B$5.1B
Total Liabilities$444.0M$621.0M$702.0M$1.3B$991.0M
Cash$371.0M$311.0M$441.0M$594.0M$434.0M
Borrowings$162.0M$203.0M$217.0M$259.0M$250.0M

Latest News

Nearly 736,000 Pillsbury rolls recalled over possible glass contamination CBS News · Jul 16, 2026 A Mineralys Insider Banked a $557,000 Options Gain Before a December FDA Date Motley Fool · Jul 16, 2026 Alex Karp Grouped Palantir With These 3 Unstoppable Stocks as the Only True Artificial Intelligence (AI) Infrastructure Winners Motley Fool · Jul 16, 2026 Southwest adds Panama City, additional Florida flights from Milwaukee Milwaukee Journal Sentinel · Jul 16, 2026 JPMorgan Just Reported $21.2 Billion in Q2 Net Income -- Up 41% -- and CEO Jamie Dimon Said the Economy Is "Close to as Good as It Gets." Motley Fool · Jul 16, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$2.3B$3.2B$3.5B$2.9B$413.0M
Investing Cash Flow$-562.0M$-847.0M$-1.6B$-564.0M$-625.0M
Financing Cash Flow$166.0M$659.0M$-10.0M$0$0
Net Cash Flow$207.0M$-60.0M$1.3B$1.5B$-160.0M
Free Cash Flow$1.8B$2.7B$2.8B$1.9B$244.0M

Valuation & Return Ratios

MetricValue
PEG Ratio6.77
EV / EBITDA21.28
FCF Yield2.13%
Quick Ratio1.55
Interest Coverage8.91
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BTTAYBiotest AG $24.21 -0.10% 48.06 $1.88B 0.00%
CMPUYCompuGroup Medical SE & Co. KGaA $23.00 -7.26% 33.82 $1.19B 0.22%
CMPVFCompuGroup Medical SE & Co. KGaA $33.66 +11.64% 94.65 $1.74B 3.51%
DGWPFDrägerwerk AG & Co. KGaA $83.00 +0.00% 10.49 $1.56B 3.12%
KARBFKaro Pharma AB (publ) $5.25 +0.00% — $1.52B 0.00%

About Biotage AB (publ)

Biotage AB (publ) specializes in advanced separation science solutions for organic and analytical chemistry, biomolecular research, and industrial-scale applications. The company's comprehensive offerings include products for organic and peptide synthesis, flash chromatography, evaporation, and sample work-up, alongside a variety of flash systems, accessories, and chromatographic cartridges (normal, reversed, and specialized phases). Additional solutions encompass plasmid purification, metal scavengers, chemical reagents, and essential spare parts. Biotage also provides extensive sample preparation systems and consumables, catering to diverse fields such as clinical, bioanalytical, forensic, toxicology, human and animal doping control, environmental analysis, and food and agriculture. Furthermore, it delivers specialized protein purification solutions, including systems for antibody and tagged protein purification, automation, custom packing services, and a range of PhyTip columns utilizing ion exchange, reversed phase, normal phase, and gel filtration technologies. Its clientele spans pharmaceutical and biotechnology companies, contract research and manufacturing organizations, government bodies, academic institutions, and various clinical and forensic laboratories. Established in 1969 and headquartered in Uppsala, Sweden, Biotage maintains a global presence, operating in 70 countries across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region.

Biotage AB (publ) is headquartered in SE.

Biotage AB (publ) (BITGF) stock trades at $15.01 with a market capitalization of $1.20B. The stock is valued at a price-to-earnings (P/E) ratio of 40.34, price-to-book of 2.79, price-to-sales of 5.58. Over the past 52 weeks the stock has ranged between $11.50 and $18.52, and currently trades 19.0% below its 52-week high. It pays a dividend yielding 1.13%.

On profitability, Biotage AB (publ) generates a return on equity (ROE) of 7.31%, return on capital employed of 8.47%, an operating margin of 18.63%, a net profit margin of 13.81%.

Official website: www.biotage.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides